ZIPRASIDONE HCL 20 MG CAPSULE
For 30 capsules
Pharmacies pay
$8.08 filed
30 × $0.2694 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$31.71 filed
30 × $1.05694 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
3.9× estimated
Medicare paid 3.9× what pharmacies pay.
Part D averages every strength and form sold under “Ziprasidone HCl” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$14.29 estimated
$8.08 + $1.21 (15%) + $5.00 fee per fill = $14.29
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
ZIPRASIDONE HCL 20 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “ziprasidone”, “ziprasidone hcl” and “ziprasidone hydrochloride”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as capsule and its route as oral.
FDA lists 10 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, NorthStar Rx LLC and Macleods Pharmaceuticals Limited.
FDA’s Established Pharmacologic Class for it is Atypical Antipsychotic.
The NADAC file of 2026-10-14 prices it under 13 NDCs (National Drug Codes); the FDA directory lists 11 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $8.08 for 30 capsules (30 × $0.2694 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 capsules · NADAC explanation codes
The 10 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Major Pharmaceuticals | 2 | $0.2694 per EA filed |
| American Health Packaging | 1 | $0.2694 per EA filed |
| Apotex Corp. | 1 | $0.2694 per EA filed |
| Aurobindo Pharma Limited | 1 | $0.2694 per EA filed |
| AvPAK | 1 | $0.2694 per EA filed |
| BluePoint Laboratories | 1 | $0.2694 per EA filed |
| Chartwell RX, LLC | 1 | $0.2694 per EA filed |
| Dr. Reddy's Laboratories Limited | 1 | $0.2694 per EA filed |
| Macleods Pharmaceuticals Limited | 1 | $0.2694 per EA filed |
| NorthStar Rx LLC | 1 | $0.2694 per EA filed |
| Not listed as a package in the FDA directory | 2 | $0.2694 per EA filed |
All 13 NDCs, with labeler and price
- 00904-6269-08 · Major Pharmaceuticals · $0.2694 per EA · eff. 2026-09-23 filed
- 00904-6269-45 · Major Pharmaceuticals · $0.2694 per EA · eff. 2026-09-23 filed
- 16714-0835-01 · NorthStar Rx LLC · $0.2694 per EA · eff. 2026-09-23 filed
- 33342-0144-09 · Macleods Pharmaceuticals Limited · $0.2694 per EA · eff. 2026-09-23 filed
- 50268-0811-11 · not listed as a package in the FDA directory · $0.2694 per EA · eff. 2026-09-23 filed
- 50268-0811-12 · AvPAK · $0.2694 per EA · eff. 2026-09-23 filed
- 55111-0256-60 · Dr. Reddy's Laboratories Limited · $0.2694 per EA · eff. 2026-09-23 filed
- 60505-2528-06 · Apotex Corp. · $0.2694 per EA · eff. 2026-09-23 filed
- 62135-0991-60 · Chartwell RX, LLC · $0.2694 per EA · eff. 2026-09-23 filed
- 65862-0702-60 · Aurobindo Pharma Limited · $0.2694 per EA · eff. 2026-09-23 filed
- 68001-0450-06 · BluePoint Laboratories · $0.2694 per EA · eff. 2026-09-23 filed
- 68084-0103-09 · American Health Packaging · $0.2694 per EA · eff. 2026-09-23 filed
- 68084-0103-11 · not listed as a package in the FDA directory · $0.2694 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
4 other products in the NADAC file share an FDA nonproprietary name with ZIPRASIDONE HCL 20 MG CAPSULE.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| GEODON 80 MG CAPSULE | $31.10811 per EA filed | We don’t know yet |
| ZIPRASIDONE HCL 20 MG CAPSULE this page | $0.2694 per EA filed | $1.05694 per EA filed |
| ZIPRASIDONE HCL 40 MG CAPSULE | $0.27223 per EA filed | $1.05694 per EA filed |
| ZIPRASIDONE HCL 60 MG CAPSULE | $0.31396 per EA filed | $1.05694 per EA filed |
| ZIPRASIDONE HCL 80 MG CAPSULE | $0.31567 per EA filed | $1.05694 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-06-03, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 13 NDCs’ NADAC prices is $0.2694 per EA filed.
Of the 130 other products in FDA’s Atypical Antipsychotic class priced per EA, 100 have a higher middle NADAC price and 30 a lower one. The one in the middle is CLOZAPINE ODT 100 MG TABLET, at $4.26464 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $31.71 for 30 capsules, at an average of $1.05694 per EA in 2024 (2024-01-01 to 2024-12-31) for “Ziprasidone HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 634,457 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for ZIPRASIDONE HCL 20 MG CAPSULE labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Ziprasidone HCl / Ziprasidone HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- QUETIAPINE 150 MG TABLET
- ARIPIPRAZOLE 10 MG TABLET
- OLANZAPINE 10 MG TABLET
- RISPERIDONE 0.25 MG TABLET
- CLOZAPINE 100 MG TABLET